PBGD assay 227!
Whole-blood samples were collected by cardiac puncture, erythrocytes purified and 228! duplicate samples from five wild-type and five heterozygous mice were analyzed for 229! PBGD activity. Whole blood samples were centrifuged at 1500×g for 10 min. The 230! plasma and buffy coat were removed. To obtain hemolysates, erythrocytes were 231! washed thrice in PBS then diluted 50-fold in the assay buffer (50 mM Tris containing 232! 0.2% Triton X-100, 20 mM citric acid, pH 8.2), incubated at 56 °C for 15 min, and 233! finally cooled on ice. Aliquots (125 µL) of the hemolysates were mixed with 245 µL 234! assay buffer containing 175 µM porphobilinogen (Sigma Aldrich, Castle Hill, 235! Australia) and incubated at 37 °C for 60 min. The reaction was terminated by adding 236! 375 µL 12.5% TCA, and oxidation of uroporphyrinogen III (URO III) to URO I was 237! allowed to occur for 30 min at ~23 °C. After centrifugation (1000×g, 5 min), 200 µL 238! of clarified supernatant was transferred to brown glass vials, stored at 4 °C, and 239! subjected to ultrahigh-performance liquid chromatography (UHPLC) within 72 h.
240!
Samples from each mouse were assayed and analyzed twice in separate reactions. The 241! UHPLC system consisted of a Dionex UltiMate™ 3000 in line with a fluorescence 242! FLD-3400 detector. A Hypersil Gold C18 column (1.9 µm particle size, 50 × 2.1 mm 243! internal diameter; Thermo Fisher Scientific, Australia) was used for elution. The 244! mobile phase consisted of 9% (v/v) acetonitrile in 1 M ammonium acetate-acetic acid 245! buffer, pH 5.16 (solvent A), and 10% acetonitrile (v/v) in methanol (solvent B) [27-246! 29] . The elution program was 0% B (100% A) for initial 2 min, 0% B (100% A) to 247! 10% B (90% A) for 2-6 min, 10% B (90% A) to 90% B (10% A) for 1 min, and 248! isocratic 90% B for further 2 min. The flow rate was set at 0.8 mL/min and column 249! temperature at 35 °C. Eluents were detected at λ ex = 404 nm and λ em = 618 nm. To 250! ! quantify standards, a solution containing 50 nmol/L URO I in 12.5% TCA was 251! prepared using a 1-mM stock solution dissolved in 1 M HCl (Sigma Aldrich). The 252! concentration of the standard was calculated using absorbance at λ = 405 nm and ε = 253! 505 × 10 3 L cm −1 mol −1 [29] . Standard curves were generated by varying the injection 254! volume and integrating the corresponding peaks. 1%O 2 /3%CO 2 /96%N 2 gas mix, and kept in an orbitally shaking incubator at 50 rpm at 264! 37°C. Culture parasitemias were maintained at between 0.5% and 10%, and checked 265! every one to two days by visualizing Giemsa-stained thin blood smear by 266! microscopy. CCM was changed every one to two days by pelleting infected cells at 267! 500xg for 5 minutes and suspending them in fresh CCM. Human erythrocytes and 268! sera were provided by the Australian Red Cross Blood Service. Blood was washed 269! thrice using CCM that lacked hypoxanthine, AlbuMAX® I, and human serum, and 270! centrifuged at 2800 RPM for 5 minutes after each wash. The P. falciparum strain 3D7 271! was donated by R. Anders (La Trobe University, Melbourne, Australia 
RESULTS

400!
Through out large-scale ENU mutagenesis screen for abnormal red blood cell count, Figure 1A ).
418!
The mutation completely segregated with the microcytic phenotype over more than 419! 10 generations of breeding. Compared to wild-type mice, reduced amounts of PBGD 420! were observed in immunoblots of proteins extracted from spleen, liver, bone marrow, 421! and erythrocytes from heterozygous mice; furthermore the truncated protein encoded 422! by Pbgd MRI58155 was not detectable ( Figure S1A and S1B). PBGD activity was 423! significantly lower in heterozygous than in wild-type erythrocytes (30.5 ± 2.2 versus 424! ! 39.5 ± 3.5 nkat/L; p = 0.048, ( Figure 1B ). Urine from heterozygous mice appeared 425! slightly pink. The heterozygous mice exhibited also modest splenomegaly, but normal 426! liver size, and normal iron content in both organs; serum cytokine levels were also 427! similar to those in wild-type mice (Tables S3 and S4 (Table 1 and Table S1 ). 
497!
We obtained these lines (designated here as PfPbgd-KO and 3D7) and compared their 498! growth characteristics using the same parasite-culturing approach described above.
499!
Two normal erythrocyte samples (HC Australia and HC Italy) and six AIP erythrocyte 500! samples (from AIP patients with mutation types A, B, C, and D) were tested. Both 501! 21 ! parasite lines cultured in the HC erythrocytes established similar parasitemia levels and 502! increased more than six-fold after 72 h. When the two lines were cultured in AIP 503! erythrocytes, the growth of PfPbgd-KO parasites was comparable to the 3D7 parasites 504! ( Figure 3A) . 505! 506! 507! Given the intraerythrocytic growth defect seen in P. chabaudi infection, we 508! investigated whether the intraerythrocytic maturation of the parasite during P. berghei 509! infection was also affected. We generated a homologue Pbgd-deficient parasite in P. 510! berghei ANKA (PbA_060800) ( Figure S2 ). Similarly to the P. falciparum ortholog, 511! the parasite developed normally along the erythrocytic stage of parasitic maturation 512! during P. berghei infection ( Figure 3B) [5, 9, 11, 15, 19] . We 554! found that P. chabaudi growth was modestly perturbed in mice but not in P. berghei 555! infected mice and human erythrocytes with reduced PBGD levels. This was 556! evidenced by reduced parasite propagation, increased intraerythrocytic parasite death, 557! and modest but significant protection against P. chabaudi infection in the 558! Pbgd MRI58155 mutant mice. Our experiments using mice and analysis of parasite 559! development in the AIP erythrocytes demonstrated that invasion of mutant 560! erythrocytes by wild-type merozoites was not inhibited. We also excluded other 561! possible indirect effects of the enzyme deficiency in the mouse, including their 562! cellular hemoglobin levels, relevant indices of which were relatively normal. We 563! therefore propose that the reason parasite P. chabaudi growth was impaired in mutant 564! mice is because that Plasmodium has a certain requirement for host PBGD. This 565! hypothesis was not supported by our observation that parasites lacking their own 566! version of Pbgd grew similarly to wild-type counterparts in AIP erythrocytes with the 567! Pbgd hypomorphic mouse mutation. It is possible the parasite requires a certain 568! threshold level of enzyme to grow, a proportion of which is likely contributed from 569! by erythrocytes; the parasitic growth defect is only manifested in host cells with 570! highly reduced PBGD levels, which was not observed in our AIP samples and Pbgd-571! deficient mouse line. It is also possible that the parasite requires precursors of the 572! heme biosynthetic pathway, which may be produced by infected host cells [14] . 
